Periodic Reporting for period 1 - ImOPac (GemciTest: An innovative In Vitro Diagnostic for the decision-making process of pancreatic cancer treatment)

What is the problem/issue being addressed?Pancreatic adenocarcinoma is predicted to be the 2nd cause of death by cancer in Western Countries in 2023. For nearly 80% of patients (~51,000 and ~150K in USA and EU patients in 2017), diagnosis occurs at an advanced, non-surgical...